Advances in NKT cell Immunotherapy for Glioblastoma

  • Pyaram K
  • Nand Yadav V
N/ACitations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myriad of cytokines which modulate the adaptive immune responses. Unlike traditional T cells which carry a conventional αβ TCR, NKT cells express semi-invariant TCR - Vα14-Jα18, coupled with Vβ8, Vβ7 and Vβ2 in mice. In humans, the invariant TCR is composed of Vα24-Jα18, coupled with Vβ11.

Cite

CITATION STYLE

APA

Pyaram, K., & Nand Yadav, V. (2018). Advances in NKT cell Immunotherapy for Glioblastoma. Journal of Cancer Science & Therapy, 10(06). https://doi.org/10.4172/1948-5956.1000533

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free